These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35543116)

  • 1. Comparison of thrombocytopenia between patients with non-alcoholic fatty liver disease and those with hepatitis C virus-related chronic liver disease.
    Kinoshita N; Shima T; Terasaki K; Oya H; Katayama T; Matsumoto J; Mitsumoto Y; Mizuno M; Mizuno C; Hirohashi R; Sakai K; Okanoue T
    Hepatol Res; 2022 Aug; 52(8):677-686. PubMed ID: 35543116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.
    Ikarashi Y; Kodama K; Taniai M; Hashimoto E; Tokushige K
    Intern Med; 2018 Apr; 57(8):1065-1070. PubMed ID: 29269684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly.
    Tejima K; Masuzaki R; Ikeda H; Yoshida H; Tateishi R; Sugioka Y; Kume Y; Okano T; Iwai T; Gotoh H; Katoh S; Suzuki A; Koike Y; Yatomi Y; Omata M; Koike K
    J Gastroenterol; 2010 Aug; 45(8):876-84. PubMed ID: 20339877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
    Ding JN; Feng TT; Sun W; Cai XY; Zhang Y; Zhao WF
    World J Gastrointest Surg; 2022 Nov; 14(11):1260-1271. PubMed ID: 36504518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis.
    Giannini E; Borro P; Botta F; Fumagalli A; Malfatti F; Podestà E; Romagnoli P; Testa E; Chiarbonello B; Polegato S; Mamone M; Testa R
    J Hepatol; 2002 Nov; 37(5):572-7. PubMed ID: 12399221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study.
    Asghar MS; Ahsan MN; Rasheed U; Hassan M; Jawed R; Abbas MB; Yaseen R; Ali Naqvi SA; Rizvi H; Syed M
    Cureus; 2020 Dec; 12(12):e12294. PubMed ID: 33520498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data.
    Yoshida M; Tateishi R; Hiroi S; Fujiwara M; Kitanishi Y; Iwasaki K; Takeshima T; Igarashi A
    Adv Ther; 2022 Feb; 39(2):992-1003. PubMed ID: 34928469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah.
    Fallatah HI; Al-Dabbagh A; Hiejazi MT; Hanbazazah SAA; Hussein AO; Al-Sahafi MA; Akbar HO
    Saudi J Med Med Sci; 2020; 8(2):118-124. PubMed ID: 32587493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the platelet count in patients with chronic hepatitis C.
    Tana MM; Zhao X; Bradshaw A; Moon MS; Page S; Turner T; Rivera E; Kleiner DE; Heller T
    Thromb Res; 2015 May; 135(5):823-8. PubMed ID: 25728497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.
    Gaia S; Campion D; Evangelista A; Spandre M; Cosso L; Brunello F; Ciccone G; Bugianesi E; Rizzetto M
    Liver Int; 2015 Aug; 35(8):2027-35. PubMed ID: 25495478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia and bleeding in veterans with non-hepatitis C-related chronic liver disease.
    Hermos JA; Altincatal A; Weber HC; Grotzinger K; Smoot KJ; Cho K; Gagnon DR; Lawler EV
    Dig Dis Sci; 2013 Feb; 58(2):562-73. PubMed ID: 23010745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases.
    Sanjo A; Satoi J; Ohnishi A; Maruno J; Fukata M; Suzuki N
    J Gastroenterol Hepatol; 2003 Jun; 18(6):638-44. PubMed ID: 12753144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker.
    Akdoğan Ö; Atak Yücel A; Gök Sargin Z; Sönmez C; Esendağli Yilmaz G; Özenirler S
    J Clin Exp Hepatol; 2019; 9(1):29-33. PubMed ID: 30765936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease.
    Kawanaka M; Nishino K; Ishii K; Tanikawa T; Urata N; Suehiro M; Sasai T; Haruma K; Kawamoto H
    World J Hepatol; 2021 May; 13(5):571-583. PubMed ID: 34131471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.
    Amernia B; Moosavy SH; Banookh F; Zoghi G
    BMC Gastroenterol; 2021 Dec; 21(1):453. PubMed ID: 34861841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study.
    Rauber P; Lammert F; Grotemeyer K; Appenrodt B
    PLoS One; 2018; 13(2):e0192271. PubMed ID: 29438423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiological Patterns, Liver Fibrosis Stages and Prescribing Patterns of Hepato-Protective Agents in Indian Patients with Chronic Liver Disease.
    Choudhuri G; Chaudhari S; Pawar D; Roy DS
    J Assoc Physicians India; 2018 Dec; 66(12):58-63. PubMed ID: 31315327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.